| scholarly article | Q13442814 |
| P356 | DOI | 10.15252/EMMM.201505748 |
| P8608 | Fatcat ID | release_yft2bkifhrckdcs3rsq3rib4pq |
| P932 | PMC publication ID | 4772952 |
| P698 | PubMed publication ID | 26896449 |
| P5875 | ResearchGate publication ID | 295246807 |
| P50 | author | Hsiang-Chun Chang | Q57027248 |
| P2093 | author name string | Ting Liu | |
| Hossein Ardehali | |||
| Chunlei Chen | |||
| Tatsuya Sato | |||
| Anita Thakur | |||
| Jason S Shapiro | |||
| Rongxue Wu | |||
| Meng Shang | |||
| Konrad T Sawicki | |||
| Sathyamangla V N Prasad | |||
| P2860 | cites work | Combined intravenous treatment with ascorbic acid and desferrioxamine to reduce myocardial reperfusion injury in an experimental model resembling the clinical setting of primary PCI | Q84266382 |
| Vitamin and Mineral Supplements in the Primary Prevention of Cardiovascular Disease and Cancer: An Updated Systematic Evidence Review for the U.S. Preventive Services Task Force | Q22241127 | ||
| Human iron-sulfur cluster assembly, cellular iron homeostasis, and disease | Q24634143 | ||
| How mitochondria produce reactive oxygen species | Q24643882 | ||
| Biogenesis of cytosolic ribosomes requires the essential iron-sulphur protein Rli1p and mitochondria | Q27939225 | ||
| Free radical production by dysfunctional eNOS | Q28256495 | ||
| Early treatment with deferoxamine limits myocardial ischemic/reperfusion injury | Q28277892 | ||
| Two to tango: regulation of Mammalian iron metabolism | Q28287034 | ||
| Iron chelation by deferoxamine inhibits lipid peroxidation during cardiopulmonary bypass in humans | Q28331733 | ||
| ROS function in redox signaling and oxidative stress | Q29615229 | ||
| The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis | Q29616568 | ||
| Selective determination of mitochondrial chelatable iron in viable cells with a new fluorescent sensor | Q31037490 | ||
| Cytoprotective efficacy and mechanisms of the liposoluble iron chelator 2,2'-dipyridyl in the rat photothrombotic ischemic stroke model. | Q33205268 | ||
| Transcriptome analysis of the ischemia-reperfused remodeling myocardium: temporal changes in inflammation and extracellular matrix. | Q33237318 | ||
| Assessment of chelatable mitochondrial iron by using mitochondrion-selective fluorescent iron indicators with different iron-binding affinities | Q33269040 | ||
| Oxidative inactivation of mitochondrial aconitase results in iron and H2O2-mediated neurotoxicity in rat primary mesencephalic cultures | Q33504558 | ||
| Expression of the yeast cation diffusion facilitators Mmt1 and Mmt2 affects mitochondrial and cellular iron homeostasis: evidence for mitochondrial iron export | Q33761323 | ||
| Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial | Q33792060 | ||
| Metabolic response to iron deficiency in Saccharomyces cerevisiae | Q33824987 | ||
| Endosomal and lysosomal effects of desferrioxamine: protection of HeLa cells from hydrogen peroxide-induced DNA damage and induction of cell-cycle arrest. | Q33973491 | ||
| Cardiac mitochondria and reactive oxygen species generation | Q33987941 | ||
| The role of iron and reactive oxygen species in cell death | Q34039363 | ||
| Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†. | Q34041875 | ||
| Glutaredoxin 2 prevents H(2)O(2)-induced cell apoptosis by protecting complex I activity in the mitochondria | Q34120771 | ||
| Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging. | Q34451519 | ||
| Reduction in hexokinase II levels results in decreased cardiac function and altered remodeling after ischemia/reperfusion injury | Q34474251 | ||
| Iron release, oxidative stress and erythrocyte ageing. | Q34574434 | ||
| Molecular bases of cellular iron toxicity | Q34615857 | ||
| The chelatable iron pool in living cells: a methodically defined quantity | Q34658929 | ||
| The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data | Q34718961 | ||
| Malfunctioning of the iron-sulfur cluster assembly machinery in Saccharomyces cerevisiae produces oxidative stress via an iron-dependent mechanism, causing dysfunction in respiratory complexes. | Q35377490 | ||
| Efficacy of the lipid-soluble iron chelator 2,2'-dipyridyl against hemorrhagic brain injury | Q35577480 | ||
| Ischemia-reperfusion injury in the aged heart: role of mitochondria | Q35599779 | ||
| Mitochondrial fission contributes to mitochondrial dysfunction and insulin resistance in skeletal muscle | Q35665651 | ||
| Disruption of ATP-binding cassette B8 in mice leads to cardiomyopathy through a decrease in mitochondrial iron export | Q35837234 | ||
| Iron trafficking in the mitochondrion: novel pathways revealed by disease. | Q35940415 | ||
| Death begets failure in the heart | Q36070078 | ||
| Effects of NO on mitochondrial function in cardiomyocytes: Pathophysiological relevance | Q36413115 | ||
| The role of oxidants and free radicals in reperfusion injury | Q36437576 | ||
| Treatment of heart failure in adults with thalassemia major: response in patients randomised to deferoxamine with or without deferiprone | Q36891845 | ||
| Regulation of iron acquisition and storage: consequences for iron-linked disorders | Q36995110 | ||
| Formation of hydrogen peroxide and reduction of peroxynitrite via dismutation of superoxide at reperfusion enhances myocardial blood flow and oxygen consumption in postischemic mouse heart | Q37040762 | ||
| Heme levels are increased in human failing hearts | Q37085606 | ||
| Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy | Q37091220 | ||
| Mitochondrial ferritin is a functional iron-storage protein in cucumber (Cucumis sativus) roots | Q37098522 | ||
| Methionine sulphoxide reductases protect iron-sulphur clusters from oxidative inactivation in yeast. | Q37122625 | ||
| Why have antioxidants failed in clinical trials? | Q37161580 | ||
| Disruption of iron homeostasis and lung disease | Q37355955 | ||
| Cardioprotective role of the mitochondrial ATP-binding cassette protein 1. | Q37372493 | ||
| Micromolar intracellular hydrogen peroxide disrupts metabolism by damaging iron-sulfur enzymes | Q37470632 | ||
| Translocation of iron from lysosomes to mitochondria during ischemia predisposes to injury after reperfusion in rat hepatocytes | Q37599003 | ||
| Redox activity within the lysosomal compartment: implications for aging and apoptosis | Q37663995 | ||
| Challenges and advances in the treatment of AKI. | Q37733599 | ||
| Mitochondrial iron metabolism and its role in neurodegeneration. | Q37750239 | ||
| Iron-dependent functions of mitochondria--relation to neurodegeneration | Q37821334 | ||
| Mitochondrial complex I. | Q38092859 | ||
| Infarct size reduction in acute myocardial infarction. | Q38211842 | ||
| Effect of iron chelation on myocardial infarct size and oxidative stress in ST-elevation-myocardial infarction. | Q38473325 | ||
| Mitochondrial DNA damage in iron overload | Q39903644 | ||
| Mitochondria transmit apoptosis signalling in cardiomyocyte-like cells and isolated hearts exposed to experimental ischemia-reperfusion injury | Q40108880 | ||
| Effect of oxidative stress on dynamics of mitochondrial reticulum. | Q40257231 | ||
| Radiation-induced cell death: importance of lysosomal destabilization | Q40438277 | ||
| Treatment with deferoxamine during ischemia improves functional and metabolic recovery and reduces reperfusion-induced oxygen radical generation in rabbit hearts | Q41784401 | ||
| Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation | Q41896006 | ||
| The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients | Q42997190 | ||
| Ferric carboxymaltose in patients with heart failure and iron deficiency | Q43240282 | ||
| Protection from reperfusion injury in the isolated rat heart by postischaemic deferoxamine and oxypurinol administration | Q43940049 | ||
| Iron deprivation decreases ribonucleotide reductase activity and DNA synthesis | Q43973445 | ||
| Intralysosomal iron: a major determinant of oxidant-induced cell death | Q44426589 | ||
| Mitochondrial Ca2+ flux and respiratory enzyme activity decline are early events in cardiomyocyte response to H2O2. | Q44970147 | ||
| Early cardiac catheterization is associated with improved survival in comatose survivors of cardiac arrest without STEMI. | Q45027721 | ||
| Deferoxamine infusion during coronary artery bypass grafting ameliorates lipid peroxidation and protects the myocardium against reperfusion injury: immediate and long-term significance | Q45200520 | ||
| Inhibition of succinate-linked respiration and complex II activity by hydrogen peroxide. | Q45961951 | ||
| Coronary venous retroinfusion of deferoxamine reduces infarct size in pigs | Q46167391 | ||
| Deaths: leading causes for 2010. | Q46317951 | ||
| Polyol pathway mediates iron-induced oxidative injury in ischemic-reperfused rat heart | Q46543545 | ||
| Beneficial effect of dipyridyl, a liposoluble iron chelator against focal cerebral ischemia: in vivo and in vitro evidence of protection of cerebral endothelial cells. | Q46821417 | ||
| Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival | Q47211077 | ||
| Failure of deferoxamine to reduce myocardial infarct size in a primate model of ischemia-reperfusion injury | Q47385734 | ||
| Decrease of myocardial infarct size with desferrioxamine: possible role of oxygen free radicals in its ameliorative effect | Q47409386 | ||
| High-Dose Iron-Chelator Therapy During Reperfusion with Deferoxamine-Hydroxyethyl Starch Conjugate Fails to Reduce Canine Infarct Size | Q47441798 | ||
| Deferoxamine pretreatment reduces canine infarct size and oxidative injury. | Q47445913 | ||
| Reduction of circulating redox-active iron by apotransferrin protects against renal ischemia-reperfusion injury | Q47949709 | ||
| The inactivation of Fe-S cluster containing hydro-lyases by superoxide. | Q52389180 | ||
| Assessment of mitochondrial respiratory chain enzymatic activities on tissues and cultured cells. | Q52625967 | ||
| Heart Failure | Q56593772 | ||
| Human Cytoplasmic Aconitase (Iron Regulatory Protein 1) Is Converted into Its [3Fe-4S] Form by Hydrogen Peroxidein Vitrobut Is Not Activated for Iron-responsive Element Binding | Q57397544 | ||
| Effect of desferrioxamine cardioplegia on ischemia-reperfusion injury in isolated rat heart | Q60586433 | ||
| Evidence that desferrioxamine cannot enter cells by passive diffusion | Q70140870 | ||
| A fluorescence assay for assessing chelation of intracellular iron in a membrane model system and in mammalian cells | Q71492847 | ||
| Desferrioxamine to improve cardiac function in iron-overloaded patients with thalassemia major | Q72571872 | ||
| Effect of ischemia/reperfusion sequence on cytosolic iron status and its release in the coronary effluent in isolated rat hearts | Q72771455 | ||
| Role of iron in ischemia-reperfusion oxidative injury of rat lungs | Q73155741 | ||
| Mitochondrial aconitase is a source of hydroxyl radical. An electron spin resonance investigation | Q73754845 | ||
| Pathways underlying iron accumulation in human nonalcoholic fatty liver disease | Q81247665 | ||
| Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury | Q81901994 | ||
| Increasing post-myocardial infarction heart failure incidence in elderly patients a call for action | Q83134651 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 3 | |
| P304 | page(s) | 247-267 | |
| P577 | publication date | 2016-03-01 | |
| P1433 | published in | EMBO Molecular Medicine | Q15817279 |
| P1476 | title | Reduction in mitochondrial iron alleviates cardiac damage during injury | |
| P478 | volume | 8 |
| Q91770878 | Acute Iron Deprivation Reprograms Human Macrophage Metabolism and Reduces Inflammation In Vivo |
| Q89631111 | Anaemia, iron homeostasis and pulmonary hypertension: a review |
| Q48623654 | Balance of cardiac and systemic hepcidin and its role in heart physiology and pathology |
| Q58563608 | Beneficial effects of intravenous iron therapy in a rat model of heart failure with preserved systemic iron status but depleted intracellular cardiac stores |
| Q99406662 | Cardiomyopathy in Sickle Cell Disease |
| Q46287398 | Dietary iron loading negatively affects liver mitochondrial function |
| Q43288665 | Getting to the "Heart" of Cardiac Disease by Decreasing Mitochondrial Iron. |
| Q90259003 | Influence of mitochondrial and systemic iron levels in heart failure pathology |
| Q52575650 | Involvement of cytosolic and mitochondrial iron in iron overload cardiomyopathy: an update. |
| Q100332993 | Iron Metabolism in Ferroptosis |
| Q90672995 | Iron and Heart Failure: Diagnosis, Therapies, and Future Directions |
| Q42336075 | Iron and Sex Cross Paths in the Heart |
| Q64386241 | Mitochondria and cardiovascular diseases-from pathophysiology to treatment |
| Q93371895 | Mitochondrial Iron in Human Health and Disease |
| Q38759545 | Mitochondrial Therapies in Heart Failure |
| Q89012656 | Pathological Roles of Iron in Cardiovascular Disease |
| Q92705211 | Pathological Roles of Mitochondrial Oxidative Stress and Mitochondrial Dynamics in Cardiac Microvascular Ischemia/Reperfusion Injury |
| Q46263621 | Protective Effects of the Mechanistic Target of Rapamycin against Excess Iron and Ferroptosis in Cardiomyocytes |
| Q104802877 | Understanding the common mechanisms of heart and skeletal muscle wasting in cancer cachexia |
Search more.